A detailed history of Cadian Capital Management, LP transactions in Maxcyte, Inc. stock. As of the latest transaction made, Cadian Capital Management, LP holds 8,188,948 shares of MXCT stock, worth $33.2 Million. This represents 1.63% of its overall portfolio holdings.

Number of Shares
8,188,948
Previous 7,622,941 7.43%
Holding current value
$33.2 Million
Previous $29.9 Million 6.61%
% of portfolio
1.63%
Previous 1.49%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$3.68 - $5.06 $2.08 Million - $2.86 Million
566,007 Added 7.43%
8,188,948 $31.9 Million
Q2 2024

Aug 14, 2024

BUY
$3.63 - $5.0 $3.86 Million - $5.31 Million
1,062,457 Added 16.19%
7,622,941 $29.9 Million
Q1 2024

May 15, 2024

BUY
$3.94 - $5.38 $3.61 Million - $4.93 Million
915,586 Added 16.22%
6,560,484 $27.5 Million
Q4 2023

Feb 14, 2024

BUY
$2.6 - $5.24 $14.7 Million - $29.6 Million
5,644,898 New
5,644,898 $26.5 Million

Others Institutions Holding MXCT

About MAXCYTE, INC.


  • Ticker MXCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 101,724,000
  • Market Cap $413M
  • Description
  • MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expr...
More about MXCT
Track This Portfolio

Track Cadian Capital Management, LP Portfolio

Follow Cadian Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cadian Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Cadian Capital Management, LP with notifications on news.